Videos | Bringing pharma’s top innovators to your screen

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Sponsored

Patient population first: the strategy behind country decisi...

Oncology

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, w...

Oncology

ASCO 2026: Pluvicto shows consistency, with Dr Fred Saad

In a conversation at ASCO 2026, Dr Fred Saad of the University of Montreal shared some insights from a subgroup analysis of Pluvicto

Oncology

ASCO 2026: All about DNA damage response, with Luke Piggot

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Digital

Inizio Ignite, STEM AI video feature image

Sponsored

STEM AI: Delivering intelligent data-led HCP interactions

In a new sponsored video, pharmaphorum spoke with experts from STEM, an Inizio Ignite company, about STEM AI

Oncology

Astellas’ banner year and focused R&D strategy, with Adam Pe...

At JPM2026, Astellas' chief strategy officer Adam Pearson walked pharmaphorum through the company’s four-pillared R&D strategy.

Patients

pharmaphorum with Repronovo's Jean Duvall during JPM2026

Bringing parity to infertility, with Jean Duvall

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

Sales & Marketing

Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Sales & Marketing

Interview at JPM26 with Helen Sabzevari and Greg Skalicky

Rewiring commercialisation to meet the moment, with Helen Sa...

At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.

Digital

Interview at Reuters Pharma EU with Florian Schnappauf, Veeva

From data to deployment: Navigating AI adoption in pharma wi...

Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.

Digital

Sponsored

STEM AI: Delivering intelligent data-led HCP interactions

In a new sponsored video, pharmaphorum spoke with experts from STEM, an Inizio Ignite company, about STEM AI

Market Access

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Market Access

Interview with Marjorie Sidhoum at BIO Europe 2026

BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...

Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.

Oncology

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, w...

Oncology

ASCO 2026: All about DNA damage response, with Luke Piggot

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Oncology

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

At ASCO 26, Daiichi Sankyo leaders Ken Keller and John Tsai chatted with pharmaphorum about their big year of oncology launches, halfway in.

Patients

ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee

R&D

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Sponsored

Patient population first: the strategy behind country decisi...

R&D

Sponsored

Decentralisation by design: Bringing the trial closer withou...

Patient population first: the strategy behind country decisi...

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, w...

ASCO 2026: Pluvicto shows consistency, with Dr Fred Saad

ASCO 2026: All about DNA damage response, with Luke Piggot

STEM AI: Delivering intelligent data-led HCP interactions

Astellas’ banner year and focused R&D strategy, with Adam Pe...

Bringing parity to infertility, with Jean Duvall

Biotech is back, with Craig Ackerman

Rewiring commercialisation to meet the moment, with Helen Sa...

From data to deployment: Navigating AI adoption in pharma wi...

STEM AI: Delivering intelligent data-led HCP interactions

Making direct-to-patient work, with Matt Wadyka

BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, w...

ASCO 2026: All about DNA damage response, with Luke Piggot

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee

ASCO 2026: Quality of life, not just quantity, with Dr Harol...

Making direct-to-patient work, with Matt Wadyka

Decentralisation by design: Bringing the trial closer withou...

Patient population first: the strategy behind country decisi...

IQVIA on reducing complexity and workload for clinical trial...

Bavarian Nordic has found its new CEO

Discover a new era of healthcare panel engagement: Grounded ...

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks